• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session

    12/6/22 1:31:35 PM ET
    $ACB
    $AMAM
    $ANEB
    $ATRO
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACB alert in real time by email

    Gainers

    • Summit Therapeutics Inc. (NASDAQ:SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific antibody, ivonescimab.
    • Pacifico Acquisition Corp. (NASDAQ:PAFO) gained 51.8% to $7.59.
    • Vivint Smart Home, Inc. (NYSE:VVNT) shares jumped 32.4% to $11.90 after NRG Energy announced it will acquire the company for $12 per share in cash.
    • Studio City International Holdings Limited (NYSE:MSC) gained 28.3% to $4.22. Studio City Intl, last month, posted a Q3 loss of $0.44 per share.
    • Starry Group Holdings, Inc. (NYSE:STRY) shares climbed 23.2% to $0.1725 after dipping more than 20% on Monday.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) rose 23% to $0.5930 after jumping over 15% on Monday. BioSig Technologies, last month, posted a Q3 loss of $0.14 per share.
    • Ra Medical Systems, Inc. (NYSE:RMED) gained 22% to $5.09.
    • Signet Jewelers Limited (NYSE:SIG) surged 19.8% to $69.28 after the company reported better-than-expected Q3 results and issued FY23 guidance above estimates.
    • SCWorx Corp. (NASDAQ:WORX) rose 17.2% to $0.78 after jumping over 18% on Monday.
    • Graphex Group Limited (NYSE:GRFX) gained 15.7% to $1.25.
    • Ballantyne Strong, Inc (NYSE:BTN) jumped 15.4% to $2.85. STRONG/MDI Screen Systems, Inc., a subsidiary of Ballantyne Strong, announced it has signed an exclusive three-year cinema screen supply agreement with Marcus Theatres.
    • Astronics Corporation (NASDAQ:ATRO) shares gained 13.4% to $10.20. The company, last month, posted downbeat quarterly results.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) jumped 13.1% to $0.6503 after the company issued a corporate update.
    • CSP Inc. (NASDAQ:CSPI) gained 13.1% to $9.46 following Q4 results.
    • Powell Industries, Inc. (NASDAQ:POWL) jumped 12.7% to $30.44 after the company reported better-than-expected Q4 results.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) rose 12.3% to $1.83. NeuroOne successfully completed its feasibility study with its OneRF Ablation System.
    • GitLab Inc. (NASDAQ:GTLB) shares rose 12.2% to $43.00 after the company reported better-than-expected Q3 results and issued FY23 guidance above estimates.
    • Sumo Logic, Inc. (NASDAQ:SUMO) rose 11.7% to $8.06 after the company reported better-than-expected Q3 results and issued strong guidance.
    • VistaGen Therapeutics, Inc. (NASDAQ:VTGN) gained 11.7% to $0.1391 after the company announced the FDA granted Fast Track designation for the development of PH10 for the treatment of major depressive disorder.
    • Bit Brother Limited (NASDAQ:BTB) rose 11.2% to $0.3891.
    • Perfect Corp. (NASDAQ:PERF) gained 9.7% to $6.34. Piper Sandler initiated coverage on Perfect with a Neutral rating and announced a price target of $7.
    • Niu Technologies (NASDAQ:NIU) gained 7.8% to $4.7450.
    • Ambrx Biopharma Inc. (NASDAQ:AMAM) shares rose 7.7% to $0.5598 after gaining 4% on Monday.
    • G-III Apparel Group, Ltd. (NASDAQ:GIII) gained 7.4% to $13.16. G-III Apparel Group CEO Morris Goldfarb bought a total of 250,000 shares at an average price of $12.54.
    • Bionano Genomics, Inc. (NASDAQ:BNGO) rose 7% to $2.1350. Bionano Genomics recently announced plans to acquire Purigen Biosystems for up to $64 million.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) rose 5% to $8.36. Mainz Biomed reported IRB approval and initiation of US pivotal FDA clinical study.


    Losers

    • Gossamer Bio, Inc. (NASDAQ:GOSS) shares dipped 70.6% to $2.7356 after the company reported announced topline results for the TORREY Phase 2 study of seralutinib in patients with pulmonary arterial hypertension (PAH).
    • Barnes & Noble Education, Inc. (NYSE:BNED) dipped 39.8% to $1.5350 after reporting downbeat Q2 earnings.
    • MEI Pharma, Inc. (NASDAQ:MEIP) fell 35% to $0.2543 after the company and Kyowa Kirin reported discontinuation of Zandelisib development outside of Japan following the recent FDA meeting.
    • Winc, Inc. (NYSE:WBEV) dropped 33% to $0.2773. NYSE American announced that the staff of NYSE Regulation determined to commence proceedings to delist the common stock of Winc from the Exchange.
    • Titan Medical Inc. (NASDAQ:TMDI) fell 31.2% to $0.58. Titan Medical implemented cost-cutting measures to support strategic review process.
    • China Automotive Systems, Inc. (NASDAQ:CAAS) dropped 27.8% to $5.67.
    • MMTec, Inc. (NASDAQ:MTC) dipped 27% to $1.0996
    • China Pharma Holdings, Inc. (NYSE:CPHI) declined 21.8% to $0.1274. China Pharma announced the acquisition of Dry Eye Disease Therapeutic Device Project.
    • Sunlands Technology Group (NYSE:STG) dropped 20.3% to $5.98.
    • Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) fell 20% to $4.20. Checkpoint Therapeutics announced a 1-for-10 reverse stock split.
    • Mirati Therapeutics, Inc.. (NASDAQ:MRTX) shares fell 19.1% to $74.92 after the company announced late-breaking results evaluating concurrent adagrasib and pembrolizumab in first-line advanced/metastatic non-small cell lung cancer.
    • Herbalife Nutrition Ltd. (NYSE:HLF) dropped 19.2% to $14.15 after the company announced a convertible senior note offering of $250 million.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) declined 18.5% to $2.4450.
    • Cosmos Holdings Inc. (NASDAQ:COSM) shares fell 17.7% to $0.4691 after gaining more than 6% on Monday.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) declined 15.7% to $4.3402.
    • BioVie Inc. (NASDAQ:BIVI) fell 14.2% to $4.47 after the company reported results for NE3107 in Parkinson's and Alzheimer's Phase 2 trials.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) dropped 14.1% to $0.2570.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) declined 13.7% to $2.9233. Anebulo Pharmaceuticals, last month, posted a Q1 loss of $0.11 per share.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 12.6% to $0.6120 after declining around 7% on Monday.
    • Palomar Holdings, Inc. (NASDAQ:PLMR) dropped 11.5% to $52.40.
    • Canopy Growth Corporation (NASDAQ:CGC) fell 10.5% to $3.8650
    • Cyxtera Technologies, Inc. (NASDAQ:CYXT) fell 10.1% to $1.96.
    • Aurora Cannabis Inc. (NASDAQ:ACB) dropped 9.5% to $1.23. Aurora Cannabis recently repurchased $76.1 million principal amount of convertible notes.
    • Stitch Fix, Inc. (NASDAQ:SFIX) declined 9.2% to $3.6610.
    • Snap Inc. (NYSE:SNAP) fell 9% to $9.19.
    • Lucid Group, Inc. (NASDAQ:LCID) dropped 8.9% to $8.59
    • Top Ships Inc. (NASDAQ:TOPS) fell 7.8% to $2.0285. TOP Ships shares dipped more than 50% on Monday after the company priced a 6.8 million unit offering at $2 per unit.

    Also check this out Bitcoin Drops But Remains Above This Key Level; GMX Becomes Top Loser.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $AMAM
    $ANEB
    $ATRO

    CompanyDatePrice TargetRatingAnalyst
    GitLab Inc.
    $GTLB
    4/22/2026$27.00Buy → Neutral
    BofA Securities
    GitLab Inc.
    $GTLB
    4/20/2026$25.00Outperform → Sector Perform
    RBC Capital Mkts
    GitLab Inc.
    $GTLB
    4/16/2026$24.00Buy → Neutral
    UBS
    Snap Inc.
    $SNAP
    4/14/2026$7.00 → $6.00Hold
    Canaccord Genuity
    GitLab Inc.
    $GTLB
    4/9/2026Buy → Neutral
    Guggenheim
    Summit Therapeutics Inc.
    $SMMT
    4/8/2026$45.00Buy
    Stifel
    Canopy Growth Corporation
    $CGC
    3/27/2026Buy
    Canaccord Genuity
    Gossamer Bio Inc.
    $GOSS
    3/23/2026Overweight → Neutral
    Cantor Fitzgerald
    More analyst ratings

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Armstrong Mac

    4 - Palomar Holdings, Inc. (0001761312) (Issuer)

    4/22/26 6:04:42 PM ET
    $PLMR
    Property-Casualty Insurers
    Finance

    SEC Form 4 filed by Briers Zachary M

    4 - Snap Inc (0001564408) (Issuer)

    4/17/26 7:00:03 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    SEC Form 4 filed by Mohan Ajit

    4 - Snap Inc (0001564408) (Issuer)

    4/17/26 7:00:07 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    $ACB
    $AMAM
    $ANEB
    $ATRO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GitLab downgraded by BofA Securities with a new price target

    BofA Securities downgraded GitLab from Buy to Neutral and set a new price target of $27.00

    4/22/26 7:53:14 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    GitLab downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded GitLab from Outperform to Sector Perform and set a new price target of $25.00

    4/20/26 8:23:59 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    GitLab downgraded by UBS with a new price target

    UBS downgraded GitLab from Buy to Neutral and set a new price target of $24.00

    4/16/26 8:00:58 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Nerges Joseph R bought $18,774 worth of shares (2,207 units at $8.51), increasing direct ownership by 0.16% to 1,411,282 units (SEC Form 4)

    4 - CSP INC /MA/ (0000356037) (Issuer)

    3/13/26 2:43:24 PM ET
    $CSPI
    EDP Services
    Technology

    Chief Business Officer Wambeke David J. bought $670,400 worth of shares (1,000,000 units at $0.67) (SEC Form 4)

    4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)

    3/3/26 8:49:19 AM ET
    $NMTC
    Medical/Dental Instruments
    Health Care

    Large owner Nerges Joseph R bought $26,366 worth of shares (3,000 units at $8.79), increasing direct ownership by 0.21% to 1,409,075 units (SEC Form 4)

    4 - CSP INC /MA/ (0000356037) (Issuer)

    2/26/26 3:27:13 PM ET
    $CSPI
    EDP Services
    Technology

    $ACB
    $AMAM
    $ANEB
    $ATRO
    SEC Filings

    View All

    SEC Form 6-K filed by Studio City International Holdings Limited

    6-K - STUDIO CITY INTERNATIONAL HOLDINGS Ltd (0001713334) (Filer)

    4/24/26 6:30:15 AM ET
    $MSC
    Hotels/Resorts
    Consumer Discretionary

    SEC Form DEFA14A filed by Lucid Group Inc.

    DEFA14A - Lucid Group, Inc. (0001811210) (Filer)

    4/23/26 6:47:55 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    SEC Form DEF 14A filed by Lucid Group Inc.

    DEF 14A - Lucid Group, Inc. (0001811210) (Filer)

    4/23/26 4:13:07 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Barnes & Noble Education to Host Investor Day on June 25, 2026

    FLORHAM PARK, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE:BNED), ("Barnes & Noble Education," "BNED," "the Company," "we," "us," "our"), a leading solutions provider for the education industry, today announced it will host a virtual Investor Day on Thursday, June 25, 2026, broadcast live from the New York Stock Exchange. During the event, BNED's leadership team will present a comprehensive overview of the Company's strategy, key growth drivers, and financial outlook. The presentation will highlight BNED's focus on improving affordability and outcomes for students, expanding its First Day® programs, and enhancing its omnichannel campus retail model to bett

    4/23/26 8:30:00 AM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign

    New window bags, improved potency, and sharper pricing arrive at retail Victoria Day long weekend Canopy Growth Corporation ("Canopy Growth", "Canopy" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423388138/en/The Tweed summer campaign launches over the Victoria Day long weekend, the traditional kickoff to the Canadian summer, spotlighting Tweed's updated portfolio, including three new flower strains and the popular Quickies pre-ro

    4/23/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    SCWorx Announces Two New Customer Wins Through Strategic Partner Channel

    New York, NY, April 22, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. ("SCWorx" or the "Company"), a leading provider of data management, analytics, and supply chain solutions for the healthcare industry, today announced that it has secured two new customers through a strategic partner relationship. Both customers are currently engaged in preparatory data initiatives in advance of planned ERP implementations. The new engagements underscore SCWorx's growing role as a critical data readiness and normalization partner in enterprise system transformations. Each customer will leverage SCWorx's platform to standardize, cleanse, and structure key operational and financial data sets required for success

    4/22/26 10:28:56 AM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Leadership Updates

    Live Leadership Updates

    View All

    'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign

    New window bags, improved potency, and sharper pricing arrive at retail Victoria Day long weekend Canopy Growth Corporation ("Canopy Growth", "Canopy" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423388138/en/The Tweed summer campaign launches over the Victoria Day long weekend, the traditional kickoff to the Canadian summer, spotlighting Tweed's updated portfolio, including three new flower strains and the popular Quickies pre-ro

    4/23/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Lucid Names Global Industrial Leader Silvio Napoli as Next Chief Executive Officer to Accelerate Growth, Profitability and Value Creation

    Silvio Napoli, formerly Chairman and Chief Executive Officer of Schindler Group, to join Lucid as next Chief Executive OfficerInterim Chief Executive Officer Marc Winterhoff will continue as Chief Operating Officer upon Napoli assuming the roleNEWARK, Calif., April 14, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced software-defined vehicles and technologies, today announced that Silvio Napoli will be Lucid's next Chief Executive Officer (CEO) and will join Lucid's Board of Directors. Mr. Napoli is currently based in Switzerland and will be relocating to the U.S. Interim Chief Executive Officer Marc Winterhoff will serve as Lucid's Chief Operating Off

    4/14/26 7:00:00 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    Canopy Growth Announces Storz & Bickel Executive Transition

    David Männer appointed Managing Director Jürgen Bickel, who co-founded and built Storz & Bickel into a global premium vaporization technology leader, passes the torch following 25 years of transformational leadership Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced the appointment of David Männer as Managing Director of Storz & Bickel, a subsidiary of Canopy Growth, effective April 1, 2026. Mr. Männer succeeds Jürgen Bickel, Storz & Bickel's Co-founder, who has decided to transition out of his role. Founded in 2001, Storz & Bickel has grown into a global leader in vaporization technology. Today, it sets the standard for innovation, p

    3/27/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Financials

    Live finance-specific insights

    View All

    China Automotive Systems Reports Record Earnings Per Share and Net Sales in 2025

    WUHAN, China, April 22, 2026 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ:CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced its unaudited financial results for the fourth quarter and the audited results for the fiscal year ended December 31, 2025. Fourth Quarter 2025 HighlightsNet sales increased by 21.4% year-over-year to $229.2 millionGross profit increased by 79.8% to $53.0 million from $29.5 million.  Gross margin of 23.1% compared to 15.6% in the fourth quarter of 2024Operating income grew 108.0% to $18.1 million, compared with $8.7 million in the fourth quarter of 2024Net income attributable to parent company's

    4/22/26 6:00:00 AM ET
    $CAAS
    Auto Parts:O.E.M.
    Consumer Discretionary

    Powell Industries Announces Date and Conference Call for Fiscal 2026 Second Quarter Results

    HOUSTON, April 20, 2026 (GLOBE NEWSWIRE) --  Powell Industries, Inc. (NASDAQ:POWL), a leading supplier of custom engineered solutions for the management, control and distribution of electrical energy, today announced that it will release results for the fiscal second quarter ended March 31, 2026 on Monday, May 4, 2026 after the market closes. In conjunction with the release, Powell Industries has scheduled a conference call, which will be broadcast live within the Investor Relations section of the Company's website, on Tuesday, May 5, 2026 at 11:00 a.m. eastern time. What:Powell Industries Fiscal 2026 Q2 Earnings Conference Call  When:Tuesday, May 5, 2026 – 11:00 a.m. eastern / 10:00 a.m.

    4/20/26 4:15:00 PM ET
    $POWL
    Electrical Products
    Energy

    Niu Technologies to Report First Quarter 2026 Financial Results on May 18, 2026

    BEIJING, April 20, 2026 (GLOBE NEWSWIRE) -- Niu Technologies ("NIU" or "the Company") (NASDAQ:NIU), the world's leading provider of smart urban mobility solutions, today announced that it will report its financial results for the first quarter 2026 before the U.S. market opens on Monday, May 18, 2026. The corporate presentation and financial spreadsheets will be posted on NIU's investor relations website at:https://ir.niu.com/financial-information/quarterly-results The Company will host an earnings conference call on Monday, May 18, 2026 at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time) to discuss the financial and business results. To join via phone, participants need to re

    4/20/26 4:00:00 AM ET
    $NIU
    Auto Manufacturing
    Industrials

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Astronics Corporation

    SC 13G - ASTRONICS CORP (0000008063) (Subject)

    12/12/24 5:27:21 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    12/5/24 7:17:43 AM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    11/26/24 5:02:01 PM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ACB
    $AMAM
    $ANEB
    $ATRO
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care